Acadia Healthcare Co (MIL:1ACHC) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1ACHC Acadia Healthcare Co Inc MIL:1ACHC
49 GF Score
Price €27.40
GF Value €32.73
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acadia Healthcare Co 5-Year EBITDA Growth Rate?

Acadia Healthcare Co MIL:1ACHC 49 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates MIL:1ACHC with a GF Score™ of 49/100 and a GF Value™ of €32.73 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Acadia Healthcare Co's EBITDA per Share for the three months ended in Jun. 2026 was €1.05.

During the past 12 months, Acadia Healthcare Co's average EBITDA Per Share Growth Rate was -252.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Acadia Healthcare Co was 69.70% per year. The lowest was -25.00% per year. And the median was 10.00% per year.


Acadia Healthcare Co  (MIL:1ACHC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Acadia Healthcare Co 5-Year EBITDA Growth Rate Related Terms


MIL:1ACHC vs OPCH, NHC, BKD: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Acadia Healthcare Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acadia Healthcare Co 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Acadia Healthcare Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Acadia Healthcare Co's 5-Year EBITDA Growth Rate falls into.


MIL:1ACHC
49GF Score
Acadia Healthcare Co Inc MIL:1ACHC
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acadia Healthcare Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Acadia Healthcare Co (MIL:1ACHC) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Acadia Healthcare Co and its competitors.
Is Acadia Healthcare Co's 5-Year EBITDA Growth Rate too high?
Acadia Healthcare Co's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Acadia Healthcare Co has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acadia Healthcare Co's 5-Year EBITDA Growth Rate compare to OPCH and NHC?
Acadia Healthcare Co's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Acadia Healthcare Co and its competitors. Acadia Healthcare Co's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acadia Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Acadia Healthcare Co (MIL:1ACHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €32.73, compared to a current price of €27.40 — trading 16.3% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Acadia Healthcare Co's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Acadia Healthcare Co (MIL:1ACHC), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acadia Healthcare Co (MIL:1ACHC) Overvalued in 2026?

Based on GuruFocus' analysis, Acadia Healthcare Co stock appears to be undervalued. The current stock price of €27.40 is trading 16.3% below its estimated GF Value™ of €32.73. GuruFocus considers Acadia Healthcare Co to be Modestly Undervalued.

Key valuation signals for MIL:1ACHC:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: €32.73 vs. price of €27.40 (16.3% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the MIL:1ACHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Acadia Healthcare Co Business Description

Address 4020 Aspen Grove Drive, Suite 900, Franklin, TN, USA, 37067
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
49GF Score

Get the complete analysis for MIL:1ACHC

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.40
Price
€32.73
GF Value